JNJ Johnson & Johnson
Pharmaceutical Preparations · NYSE · SEC EDGAR official
Market Value*
$367.00B
Revenue (FY)
$94.19B 2025-12-28
Net Income (FY)
$26.80B
P/E (float-based)
13.7
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer.